Mapping SARS-CoV-2 antigenic relationships and serological responses.

dc.contributor.author

Wilks, Samuel H

dc.contributor.author

Mühlemann, Barbara

dc.contributor.author

Shen, Xiaoying

dc.contributor.author

Türeli, Sina

dc.contributor.author

LeGresley, Eric B

dc.contributor.author

Netzl, Antonia

dc.contributor.author

Caniza, Miguela A

dc.contributor.author

Chacaltana-Huarcaya, Jesus N

dc.contributor.author

Corman, Victor M

dc.contributor.author

Daniell, Xiaoju

dc.contributor.author

Datto, Michael B

dc.contributor.author

Dawood, Fatimah S

dc.contributor.author

Denny, Thomas N

dc.contributor.author

Drosten, Christian

dc.contributor.author

Fouchier, Ron AM

dc.contributor.author

Garcia, Patricia J

dc.contributor.author

Halfmann, Peter J

dc.contributor.author

Jassem, Agatha

dc.contributor.author

Jeworowski, Lara M

dc.contributor.author

Jones, Terry C

dc.contributor.author

Kawaoka, Yoshihiro

dc.contributor.author

Krammer, Florian

dc.contributor.author

McDanal, Charlene

dc.contributor.author

Pajon, Rolando

dc.contributor.author

Simon, Viviana

dc.contributor.author

Stockwell, Melissa S

dc.contributor.author

Tang, Haili

dc.contributor.author

van Bakel, Harm

dc.contributor.author

Veguilla, Vic

dc.contributor.author

Webby, Richard

dc.contributor.author

Montefiori, David C

dc.contributor.author

Smith, Derek J

dc.date.accessioned

2023-11-01T13:43:47Z

dc.date.available

2023-11-01T13:43:47Z

dc.date.issued

2023-10

dc.date.updated

2023-11-01T13:43:46Z

dc.description.abstract

During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, multiple variants escaping preexisting immunity emerged, causing reinfections of previously exposed individuals. Here, we used antigenic cartography to analyze patterns of cross-reactivity among 21 variants and 15 groups of human sera obtained after primary infection with 10 different variants or after messenger RNA (mRNA)-1273 or mRNA-1273.351 vaccination. We found antigenic differences among pre-Omicron variants caused by substitutions at spike-protein positions 417, 452, 484, and 501. Quantifying changes in response breadth over time and with additional vaccine doses, our results show the largest increase between 4 weeks and >3 months after a second dose. We found changes in immunodominance of different spike regions, depending on the variant an individual was first exposed to, with implications for variant risk assessment and vaccine-strain selection.

dc.identifier.issn

0036-8075

dc.identifier.issn

1095-9203

dc.identifier.uri

https://hdl.handle.net/10161/29318

dc.language

eng

dc.publisher

American Association for the Advancement of Science (AAAS)

dc.relation.ispartof

Science (New York, N.Y.)

dc.relation.isversionof

10.1126/science.adj0070

dc.title

Mapping SARS-CoV-2 antigenic relationships and serological responses.

dc.type

Journal article

duke.contributor.orcid

Shen, Xiaoying|0000-0001-8076-1931|0000-0002-8387-3952

duke.contributor.orcid

Montefiori, David C|0000-0003-0856-6319

pubs.begin-page

eadj0070

pubs.issue

6666

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Medicine

pubs.organisational-group

Surgery

pubs.organisational-group

Medicine, Duke Human Vaccine Institute

pubs.organisational-group

Surgery, Surgical Sciences

pubs.organisational-group

Duke Human Vaccine Institute

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

University Institutes and Centers

pubs.organisational-group

Duke Global Health Institute

pubs.publication-status

Published

pubs.volume

382

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMID37797027.pdf
Size:
2.49 MB
Format:
Adobe Portable Document Format